Participated · Seed · Jul 2025

BosonQ Psi’s core product is the Physics-Constrained Quantum-Assisted Machine Learning (PC-QAML) platform, which combines physics-based modeling with quantum-inspired computational techniques to perform AI inference. The platform is designed to run directly on space-qualified processors instead of relying on cloud or GPU-based computing. BQP plans to use its SpaceWERX SBIR award to develop and validate a software application that improves the speed and accuracy of identifying unknown objects and behaviors in space. The company positions its technology to operate on satellites and forward-deployed systems with limited computing power and intermittent communications. BQP has previously worked with the Space Domain Awareness Tap Lab and supports mission objectives for Space Operations Command Mission Delta 2 and Space Systems Command. The article notes this is BQP’s first federal contract.

Led · Equity · Oct 2024

Ozlo sells Sleepbuds, a compact pair of sleep-focused earbuds that support streaming and reuse licensed IP and design expertise from former Bose sleep-product engineers. The buds sit flush with the ear, use soft compliant tips with small wing tips for retention, and come in a puck-shaped charging case. Ozlo priced the Sleepbuds at $299 and began shipping units to early backers while making them broadly available for purchase. The company says it will use new capital to develop a second-generation Sleepbuds product and to pursue FDA clearance for a tinnitus therapy. Ozlo’s positioning ties the hardware to a broader health play within wearables rather than being a pure hardware-only maker. The team and product lineage trace back to former Bose executives and licensed Bose IP, which helped accelerate the product’s development and market entry. Ozlo Sleep is a Boston, MA-based science-driven sleep and audio technology company focused on clinically enhancing rest without pharmaceutical intervention. It was co-founded by three ex-Bose employees, including CEO N.B. Patil, COO Brian Mulcahey, and CPO Charles Taylor. The company's core product is Ozlo Sleepbuds, a headphone designed specifically for sleep that leverages acquired and licensed proprietary sleep-related technology from Bose Corporation. Ozlo emerged from stealth after completing a $10M Series A and plans to launch the Sleepbuds later this summer. The funding round was led by LifeArc Ventures and ARTIS Ventures, and board seats were added for Dr. Imran Hamid and Vasudev Bailey. Ozlo's stated mission is to improve wakefulness and the quality of mental and physical well-being by enhancing rest through audio and sleep science.

Participated · Series A · Jun 2024

Exsilio Therapeutics develops genomic medicines designed to permanently insert therapeutic genes via RNA intermediate templates and deliver them in lipid nanoparticles. Its technology is based on naturally occurring genetic elements engineered through predictive in silico modeling and wet lab experimentation for precise insertion into safe-harbor sites of disease-relevant cells. The company aims to treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions, by encoding genes that integrate permanently rather than producing transient effects. Exsilio plans to use its platform to insert whole genes with a repeatable and titratable approach, potentially addressing patients irrespective of individual mutations. Led by CEO Tal Zaks, the company intends to advance lead candidates toward development and expand operations using the new financing. The article does not disclose revenue or user metrics.

Participated · Seed · Nov 2021

Nirvana provides an AI-powered platform that delivers instant insurance verification and highly accurate cost estimates to providers and patients. Its Discover technology can retrieve complete eligibility using only name, date of birth, and ZIP code, and handles data-entry errors. The product is available via direct API, EHR/EMR integrations, and a web/mobile OneVerify application. Nirvana was built for behavioral health and has expanded into sectors including physical therapy, intensive outpatient, and primary care. The company adapts its models using patterns from its millions of monthly eligibility checks to handle specialty-specific insurance nuances. Nirvana recently raised a $24.2M Series A to support expansion into additional specialties and scale its eligibility management platform. Nirvana offers a practice management platform for mental health professionals that centralizes back-office workflows. The platform streamlines insurance workflows for enterprise and solo practices through integrations with top mental-healthcare insurers. It also unifies financial management for practices and enables building patient-facing experiences. Launched in 2020 by CEO Akshay Venkitasubramanian, the company targets therapists and enterprise customers across the U.S. Nirvana plans to use new capital to expand its engineering, customer success, and sales teams and to bring its technology to more therapists and enterprises. To date the company has raised nearly $12M. Nirvana Health provides a practice-management platform that automates insurance authorizations, claims filing (in- and out-of-network), payment processing, and appointment management tailored to mental-health therapists. The company uses AI and machine learning to reduce manual back-office work and add transparency to patient benefits and session costs. It serves several hundred therapists today and has recovered more than $1 million in therapy-session reimbursements for consumers through its paperwork automation. Nirvana is working to scale into a self-serve platform, deepen payment-chain integrations, and enable large enterprises, teletherapy marketplaces, and EAPs to onboard therapists. The product aims to increase therapist capacity by removing administrative friction so clinicians can see more clients and accept a wider range of patients.